Fenofibrate Tablet, Film Coated
Product Images NDC 51407-093

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Fenofibrate (NDC 51407-093). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Golden State Medical Supply, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

51407 093 90

The text describes a medication product manufactured by Teva Pharmaceutical Industries LTD and packaged by GSMS Incorporate. The medication is in tablet form, with each coating containing 54mg of the drug Fenofibrate, and the entire package contains 90 tablets. The medication should be stored between 20° to 25°C and protected from moisture. Dosage information is provided in the package insert. It is advised to keep the medication out of reach of children and stored in a tight, light-resistant container with a child-resistant closure.*

FDA Label Image

51407 094 90

This is a bottle of Fenofibrate, a medicine used for reducing cholesterol and triglycerides levels in the blood. It contains 90 film-coated tablets of 160 mg of Fenofibrate USP each, and includes an insert with dosage information as well as safety information. The medicine should be stored in a cool and dry place, away from moisture, and out of reach of children. The container must be tight and light-resistant, with a child-resistant closure. This bottle was manufactured by TEVAPHARMAGEUTICAL, IND. LTD. in Israel and packaged by GSMS, Incorporated in the USA.*

FDA Label Image

Chemical Structure (Structure 01)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.